The pharmaceutical market in Russia ranks among the top twenty markets in the world with the potential to move up in ranking rather quickly. This market will be one of several that major pharmaceutical companies are exploring for new opportunities for growth. Reliance on commodity prices makes Russia's economy and government spending on healthcare variable, but awareness of healthcare issues, especially among the younger population, and a willingness to spend personal funds on healthcare will drive Russian markets.

For the purpose of this study six general segments are listed with a final segment including all other drug classes not listed. The specific segments outlined include:

• Cardiovascular drugs
• Gastrointestinal drugs
• Infection control drugs
• Neurotherapeutics/CNS drugs
• Oncology drugs
• Respiratory drugs
• Others

The report includes incidence of conditions prevalent in the region discussed, health statistics related to the industry, birth rates, world population, populations by region and issues affecting the market as a whole. The market chapter provides an overview of demographics, information about products segments and market indicators, market estimates and forecasts. The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study, Kalorama Information conducted interviews with more than 80 key industry officials, consultants, health care providers, and government personnel. These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report. Additional interviews were completed with relevant company representatives including marketing directors, division managers, and product representatives.

As part of its research, this report includes:

• Demographic Statistics
• Available Russian Pharmaceutical Market
• Current Market Share of Major Companies
• Market by Therapeutic Product Area
• Forecast by Therapeutic Product Area
• Foreign vs. Local Market
• Profiles of Major Companies in Russia

All market data pertains to the world market at the manufacturers’ level. The base year for data was 2007. Historical data was provided for the years 2005 and 2006, with forecast data provided for 2008 through 2012. Compound annual growth rates (CAGRs) are provided for the 2005-2007 and 2008-2012 periods for each region and/or segment covered. The forecasted market analysis for 2008-2012 was largely based on demographic trends, new developments, and global expansion.

Related Reports:

The World Market for Biosimilars and the Potential for US Follow-on Biologics
Aug 1, 2009 - KLI2402283 - $3,700.00

Rx to OTC Switches 2009
May 1, 2009 - KLI2196300 - $3,500.00

Pharmaceutical Markets in India
Apr 1, 2009 - KLI2155338 - $1,295.00

Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition
Jan 1, 2009 - KLI1646605 - $3,500.00

Effective Competitive Intelligence: A "How-To" Guide for Life Science Companies
Nov 1, 2008 - KLI1807610 - $499.00

Pharmaceutical Markets in the Middle East (Opportunities, Key Players, Trends in Egypt, Jordan, Israel, Saudi Arabia and UAE)
Nov 1, 2008 - KLI1646593 - $3,300.00

Key Healthcare Opportunities for Technology Companies (Wireless in Healthcare 2008-12, High-Tech Patient Monitoring Systems, RFID in Pharma Manufacturing, US EMR Markets, RFID in Healthcare, Electronic Components for Medical Device Markets)
Oct 1, 2008 - KLI1927818 - $7,995.00

Pharmaceutical Markets in Brazil, Russia, India and China ( BRIC nations )
Jul 1, 2008 - KLI1614109 - $2,500.00

Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
May 1, 2008 - KLI1646603 - $3,500.00

World OTC Pharmaceutical Markets: Self-Medication, Developing and Petro-Based Economies, BTC and Other Growth Trends
May 1, 2008 - KLI1614108 - $3,200.00